Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency
Status:
Completed
Trial end date:
2005-03-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to show that Protein C Concentrate is a safe and effective
treatment for subjects with congenital protein C deficiency. Depending on the type of
treatment required, patients are assigned to one of 3 study parts: Part 1 is for the
treatment of acute episodes, Part 2 is for short-term prophylaxis, and Part 3 is for
long-term prophylaxis in infants aged less than 6 months only.